BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drolet BA, Swanson EA, Frieden IJ; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008;153:712-715, 715.e1. [PMID: 18940356 DOI: 10.1016/j.jpeds.2008.05.043] [Cited by in Crossref: 117] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Mcswiney E, Murray D, Murphy M. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure. Eur J Pediatr 2014;173:63-8. [DOI: 10.1007/s00431-013-2105-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Amrock SM, Weitzman M. Diverging racial trends in neonatal infantile hemangioma diagnoses, 1979-2006. Pediatr Dermatol 2013;30:493-4. [PMID: 23331036 DOI: 10.1111/pde.12075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Kim JH, Lam JM. Paediatrics: how to manage infantile haemangioma. Drugs Context 2021;10:2020-12-6. [PMID: 33889196 DOI: 10.7573/dic.2020-12-6] [Reference Citation Analysis]
4 Edwards AK, Glithero K, Grzesik P, Kitajewski AA, Munabi NC, Hardy K, Tan QK, Schonning M, Kangsamaksin T, Kitajewski JK, Shawber CJ, Wu JK. NOTCH3 regulates stem-to-mural cell differentiation in infantile hemangioma. JCI Insight 2017;2:93764. [PMID: 29093274 DOI: 10.1172/jci.insight.93764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
5 Wu C, Guo L, Wang L, Li J, Wang C, Song D. Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol. Medicine (Baltimore) 2019;98:e14346. [PMID: 30732164 DOI: 10.1097/MD.0000000000014346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Hudalla H, Karmen C, Bruckner T, Wallwiener S, Fluhr H, Michael Z, Freis A, Maul H, Strowitzki T, Pöschl J, Kuon RJ. Tocolysis with the β2-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants. Arch Gynecol Obstet 2018;298:521-7. [PMID: 29938346 DOI: 10.1007/s00404-018-4830-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Hartmann F, Lockmann A, Grönemeyer LL, Haenssle HA, Zutt M, von Fintel H, Kühnle I, Schön MP, Thoms KM. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children. J Eur Acad Dermatol Venereol 2017;31:1372-9. [PMID: 27911476 DOI: 10.1111/jdv.14074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
8 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
9 Mull JL, Chamlin SL, Lai JS, Beaumont JL, Cella D, Rancour EA, Baselga E, Haggstrom AN. Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment. Pediatr Dermatol 2017;34:78-83. [PMID: 27981617 DOI: 10.1111/pde.13032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Uihlein LC, Liang MG, Mulliken JB. Pathogenesis of Infantile Hemangiomas. Pediatr Ann 2012;41:1-6. [DOI: 10.3928/00904481-20120727-08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Elluru RG. Cutaneous Vascular Lesions. Facial Plastic Surgery Clinics of North America 2013;21:111-26. [DOI: 10.1016/j.fsc.2012.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am 2014;61:383-402. [PMID: 24636652 DOI: 10.1016/j.pcl.2013.11.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
13 Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol 2016;74:120-6. [PMID: 26494585 DOI: 10.1016/j.jaad.2015.08.024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
14 Buckmiller L, Richter G, Suen J. Diagnosis and management of hemangiomas and vascular malformations of the head and neck: Managing vascular anomalies. Oral Diseases 2010;16:405-18. [DOI: 10.1111/j.1601-0825.2010.01661.x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 117] [Article Influence: 13.4] [Reference Citation Analysis]
15 Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269-274. [PMID: 20456345 DOI: 10.1111/j.1365-2133.2010.09848.x] [Cited by in Crossref: 308] [Cited by in F6Publishing: 258] [Article Influence: 25.7] [Reference Citation Analysis]
16 Li M, Chen Y, Guo Z, Xie Y, Zhou Y, Jiang C, Chen X. The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma. Arch Dermatol Res 2017;309:169-78. [PMID: 28197761 DOI: 10.1007/s00403-017-1716-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Goelz R, Moll M, Meisner C, Röcken M, Poets CF, Moehrle MC. Prospective controlled study to evaluate cryocontact therapy for infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed 2014;99:F345.1-F346. [DOI: 10.1136/archdischild-2013-304577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Chen XD, Ma G, Chen H, Ye XX, Jin YB, Lin XX. Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Case-Control Study. Pediatr Dermatol 2013;30:457-61. [DOI: 10.1111/pde.12042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
19 Filippi L, Cavallaro G, Fiorini P, Malvagia S, Della Bona M, Giocaliere E, Bagnoli P, Dal Monte M, Mosca F, Donzelli G, la Marca G. Propranolol concentrations after oral administration in term and preterm neonates. The Journal of Maternal-Fetal & Neonatal Medicine 2013;26:833-40. [DOI: 10.3109/14767058.2012.755169] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
20 Goldberg V, Martinez B, Cnop K, Rohloff P. Use of propranolol in a remote region of rural Guatemala to treat a large facial infantile haemangioma. BMJ Case Rep 2017;2017:bcr-2017-219782. [PMID: 28512124 DOI: 10.1136/bcr-2017-219782] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Gupta D, Sidbury R. Cutaneous Congenital Defects. Avery's Diseases of the Newborn. Elsevier; 2018. pp. 1511-1535.e4. [DOI: 10.1016/b978-0-323-40139-5.00107-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Su WT, Xue JX, Ke YH. Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review. World J Clin Cases 2019; 7(14): 1876-1883 [PMID: 31417934 DOI: 10.12998/wjcc.v7.i14.1876] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Yu L, Li LL, Yan P, Deng L, Gan XL, Yao XJ, Zhu ZH, Zhang TD. Clinical characteristics of lip infantile haemangiomas and main risk factors for ulceration: an 8-year retrospective study of 69 Chinese infants. J Eur Acad Dermatol Venereol 2020;34:2135-9. [PMID: 32118308 DOI: 10.1111/jdv.16331] [Reference Citation Analysis]
24 Ji Y, Chen S, Li K, Xiao X, Zheng S, Xu T. The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Div 2013;8:1. [PMID: 23286511 DOI: 10.1186/1747-1028-8-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
25 Greco MF, Frieden IJ, Drolet BA, Garzon MC, Mancini AJ, Chamlin SL, Metry D, Adams D, Lucky A, Wentzel MS, Horii KA, Baselga E, McCuaig CC, Powell J, Haggstrom A, Siegel D, Morel KD, Cordisco MR, Nopper AJ, Krol A; Hemangioma Investigator Group. Infantile Hemangiomas in Twins: A Prospective Cohort Study. Pediatr Dermatol 2016;33:178-83. [PMID: 26863906 DOI: 10.1111/pde.12781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Couto RA, Hassanein AH, Maclellan RA, Greene AK. Infantile hemangioma in four siblings. Pediatr Dermatol 2013;30:e14-5. [PMID: 22784313 DOI: 10.1111/j.1525-1470.2012.01779.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
27 Blanke K, Dähnert I, Salameh A. Role of connexins in infantile hemangiomas. Front Pharmacol 2013;4:41. [PMID: 23596415 DOI: 10.3389/fphar.2013.00041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
28 Sugimoto A, Aoki R, Toyohara E, Ogawa R. Infantile Hemangiomas Cleared by Combined Therapy With Pulsed Dye Laser and Propranolol. Dermatol Surg 2021;47:1052-7. [PMID: 34397540 DOI: 10.1097/DSS.0000000000003018] [Reference Citation Analysis]
29 Sipkova Z, Xue K, Mudhar HS, Wagner B, Hildebrand GD. Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5. Ocul Oncol Pathol 2018;4:100-6. [PMID: 30320089 DOI: 10.1159/000477411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Strumila A, Dagilytė RV, Beiša V. Recommendations and a guideline for referral of infantile haemangioma to tertiary centres. Acta Med Litu 2018;25:38-44. [PMID: 29928156 DOI: 10.6001/actamedica.v25i1.3702] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Frieden IJ, Drolet BA. Propranolol for Infantile Hemangiomas: Promise, Peril, Pathogenesis. Pediatric Dermatology 2009;26:642-4. [DOI: 10.1111/j.1525-1470.2009.00977.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
32 Kawaguchi A, Kunimoto K, Inaba Y, Mikita N, Kaminaka C, Kanazawa N, Yamamoto Y, Kakimoto N, Suenaga T, Takeuchi T, Suzuki H, Baba N, Jinnin M. Distribution analysis of infantile hemangioma or capillary malformation on the head and face in Japanese patients. J Dermatol 2019;46:849-52. [PMID: 31418467 DOI: 10.1111/1346-8138.15051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Puttgen KB, Pearl M, Tekes A, Mitchell SE. Update on pediatric extracranial vascular anomalies of the head and neck. Childs Nerv Syst 2010;26:1417-33. [DOI: 10.1007/s00381-010-1202-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
34 Queisser A, Seront E, Boon LM, Vikkula M. Genetic Basis and Therapies for Vascular Anomalies. Circ Res 2021;129:155-73. [PMID: 34166070 DOI: 10.1161/CIRCRESAHA.121.318145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kaune KM, Lauerer P, Kietz S, Eich C, Thoms KM, Schön MP, Zutt M. Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe. J Dtsch Dermatol Ges 2014;12:473-8. [PMID: 24825388 DOI: 10.1111/ddg.12354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Rodríguez Bandera AI, Sebaratnam DF, Wargon O, Wong LF. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. J Am Acad Dermatol 2021:S0190-9622(21)02351-3. [PMID: 34419524 DOI: 10.1016/j.jaad.2021.08.019] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, Alió AB, Ritter M, Friedlander DF, Catanzarite V. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170:907-913. [PMID: 24641194 DOI: 10.1111/bjd.12804] [Cited by in Crossref: 121] [Cited by in F6Publishing: 97] [Article Influence: 17.3] [Reference Citation Analysis]
38 Juern AM, Glick ZR, Drolet BA, Frieden IJ. Nevus simplex: A reconsideration of nomenclature, sites of involvement, and disease associations. Journal of the American Academy of Dermatology 2010;63:805-14. [DOI: 10.1016/j.jaad.2009.08.066] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
39 Truong MT, Chang KW, Berk DR, Heerema-mckenney A, Bruckner AL. Propranolol for the Treatment of a Life-Threatening Subglottic and Mediastinal Infantile Hemangioma. The Journal of Pediatrics 2010;156:335-8. [DOI: 10.1016/j.jpeds.2009.10.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
40 Fevurly RD, Fishman SJ. Vascular Anomalies in Pediatrics. Surgical Clinics of North America 2012;92:769-800. [DOI: 10.1016/j.suc.2012.03.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
41 Kurachi A, Ozaki M, Ihara A, Eto H, Takushima A. Eyelid Thread-lifting Treatment for Periocular Infantile Hemangioma in an Extremely Premature Low-birth-weight Infant. Plast Reconstr Surg Glob Open 2019;7:e2373. [PMID: 31592024 DOI: 10.1097/GOX.0000000000002373] [Reference Citation Analysis]
42 Tiemann L, Hein S. Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls.J Pediatr Pharmacol Ther. 2020;25:586-599. [PMID: 33041713 DOI: 10.5863/1551-6776-25.7.586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jinnin M, Ishihara T, Boye E, Olsen BR. WITHDRAWN; Recent progress in studies of infantile hemangioma: Progress in studies of infantile hemangioma. The Journal of Dermatology 2010;37:939-55. [DOI: 10.1111/j.1346-8138.2010.00927.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
44 Murphy T, Ramai D, Lai J, Sullivan K, Grimes C. Adult neck hemangiolymphangioma: a case and review of its etiology, diagnosis and management. J Surg Case Rep 2017;2017:rjx168. [PMID: 28928923 DOI: 10.1093/jscr/rjx168] [Reference Citation Analysis]
45 Maguiness S, Frieden I. Infantile Hemangiomas: A Look Back and Future Directions. Actas Dermo-Sifiliográficas 2009;100:73-6. [DOI: 10.1016/s0001-7310(09)73170-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
46 Zou H, Jia J, Zhang W, Sun Z, Zhao Y. Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma. Cardiovascular Pathology 2013;22:203-10. [DOI: 10.1016/j.carpath.2012.10.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
47 Alniemi ST, Griepentrog GJ, Diehl N, Mohney BG. Incidence and clinical characteristics of periocular infantile hemangiomas. Arch Ophthalmol 2012;130:889-93. [PMID: 22776927 DOI: 10.1001/archophthalmol.2012.213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Yao TH, Pataer P, Regmi KP, Gu XW, Li QY, Du JT, Ge SM, Tu JB. Propranolol induces hemangioma endothelial cell apoptosis via a p53BAX mediated pathway. Mol Med Rep. 2018;18:684-694. [PMID: 29767244 DOI: 10.3892/mmr.2018.9013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
49 Bota M, Popa G, Blag C, Tataru A. Infantile Hemangioma: A Brief Review. Clujul Med 2015;88:23-7. [PMID: 26528043 DOI: 10.15386/cjmed-381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
50 Duan P, Huang Y, Chen K, Cheng C, Wu Z, Wu Y. 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1. Int J Med Sci 2021;18:3214-23. [PMID: 34400891 DOI: 10.7150/ijms.60774] [Reference Citation Analysis]
51 Moyakine AV, Vleuten CJVD. Propranolol for infantile hemangioma: Current state of affairs. World J Dermatol 2016; 5(1): 4-16 [DOI: 10.5314/wjd.v5.i1.4] [Reference Citation Analysis]
52 Frommelt P, Juern A, Siegel D, Holland K, Seefeldt M, Yu J, Uhing M, Wade K, Drolet B. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol 2016;33:405-14. [DOI: 10.1111/pde.12869] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
53 Mai C, Vega-pérez A, Koch M, Bertelmann E. Erfolgreiche Behandlung eines kapillären orbitalen Hämangioms mit Propranolol. Ophthalmologe 2011;108:364-7. [DOI: 10.1007/s00347-010-2281-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Bota M, Popa G, Blag CL, Leucuta DC, Tătaru A. Infantile hemangiomas: a 7-year experience of a single-center. Clujul Med 2017;90:396-400. [PMID: 29151787 DOI: 10.15386/cjmed-781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Neri I, Balestri R, Patrizi A. Hemangiomas: new insight and medical treatment: Hemangiomas: new insight and medical treatment. Dermatol Ther 2012;25:322-34. [DOI: 10.1111/j.1529-8019.2012.01481.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
56 Hoeger PH. Infantile haemangioma: new aspects on the pathogenesis of the most common skin tumour in children. Br J Dermatol. 2011;164:234-235. [PMID: 21271990 DOI: 10.1111/j.1365-2133.2011.10204.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
57 Casini G, Dal Monte M, Fornaciari I, Filippi L, Bagnoli P. The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases. Progress in Retinal and Eye Research 2014;42:103-29. [DOI: 10.1016/j.preteyeres.2014.06.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
58 de Jong S, Itinteang T, Withers AH, Davis PF, Tan ST. Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res. 2016;308:219-227. [PMID: 26940670 DOI: 10.1007/s00403-016-1635-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
59 Ding Y, Zhang J, Yu S, Xiang F, Kang X. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr 2020;16:377-84. [DOI: 10.1007/s12519-019-00327-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
60 Hunjan MK, Schoch JJ, Anderson KR, Lohse CM, Marnach ML, Hand JL, Davis DMR, Tollefson MM. Prenatal Risk Factors for Infantile Hemangioma Development. J Invest Dermatol 2017;137:954-7. [PMID: 27940221 DOI: 10.1016/j.jid.2016.10.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
61 Jinnin M, Ishihara T, Boye E, Olsen BR. Recent progress in studies of infantile hemangioma. J Dermatol 2010;37:283-98. [PMID: 20507397 DOI: 10.1111/j.1346-8138.2010.00813.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
62 Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011;38:45-63. [PMID: 21095471 DOI: 10.1016/j.cps.2010.08.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
63 Kado M, Shimizu A, Matsumura T, Mochizuki M, Mizuno H, Hayashi A. Successful Treatment of Infantile Hemangiomas With Propranolol in Low-Birth-Weight Infants: . Journal of Craniofacial Surgery 2017;28:789-93. [DOI: 10.1097/scs.0000000000003542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Mahady K, Thust S, Berkeley R, Stuart S, Barnacle A, Robertson F, Mankad K. Vascular anomalies of the head and neck in children. Quant Imaging Med Surg 2015;5:886-97. [PMID: 26807370 DOI: 10.3978/j.issn.2223-4292.2015.04.06] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
65 Cai Y, Lv F, Kaldybayeva N, Zhamilya A, Wu Z, Wu Y. 15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo. Front Pharmacol. 2018;9:25. [PMID: 29441017 DOI: 10.3389/fphar.2018.00025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
66 Xu W, Li S, Yu F, Zhang Y, Yang X, An W, Wang W, Sun C. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma. Plast Reconstr Surg 2018;142:310e-21e. [PMID: 30148773 DOI: 10.1097/PRS.0000000000004684] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
67 Kaneko T, Sasaki S, Baba N, Koh K, Matsui K, Ohjimi H, Hayashi N, Nakano A, Ohki K, Kuwano Y, Morimoto A, Tamaki Z, Kakazu M, Kishi K, Oyama T, Sato A, Kato R, Higuchi T. Efficacy and safety of oral propranolol for infantile hemangioma in Japan. Pediatrics International 2017;59:869-77. [DOI: 10.1111/ped.13318] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
68 Materna-Kiryluk A, Wiśniewska K, Więckowska B, Wróblewska-Seniuk K, Jaroszewska-Świątek B, Helwich E, Latos-Bieleńska A. Genetic and Environmental Risk Factors for Isolated Hemangiomas in Infants. Children (Basel) 2020;7:E150. [PMID: 32992757 DOI: 10.3390/children7100150] [Reference Citation Analysis]
69 Auger N, Fraser W, Arbour L, Healy‐profitós J, Drolet B. Pre‐eclampsia and risk of infantile haemangioma. Br J Dermatol 2017;176:371-7. [DOI: 10.1111/bjd.14958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Callahan AB, Yoon MK. Infantile hemangiomas: A review. Saudi J Ophthalmol 2012;26:283-91. [PMID: 23961007 DOI: 10.1016/j.sjopt.2012.05.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
71 Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25:1245-1253. [PMID: 21569112 DOI: 10.1111/j.1468-3083.2011.04102.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
72 Torres E, Rosa J, Leaute-Labreze C, Soares-de-Almeida L. Multifocal infantile haemangioma: a diagnostic challenge. BMJ Case Rep 2016;2016:bcr2016214827. [PMID: 27317759 DOI: 10.1136/bcr-2016-214827] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Auger N, Ayoub A, Lo E, Luu TM. Increased risk of hemangioma after exposure to neonatal phototherapy in infants with predisposing risk factors. Acta Paediatr 2019;108:1447-52. [PMID: 30681210 DOI: 10.1111/apa.14727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Holland KE, Drolet BA. Approach to the patient with an infantile hemangioma. Dermatol Clin 2013;31:289-301. [PMID: 23557656 DOI: 10.1016/j.det.2012.12.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
75 Fluhr JW, Darlenski R, Taieb A, Hachem JP, Baudouin C, Msika P, De Belilovsky C, Berardesca E. Functional skin adaptation in infancy - almost complete but not fully competent. Exp Dermatol 2010;19:483-92. [PMID: 20353516 DOI: 10.1111/j.1600-0625.2009.01023.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
76 Byun JW, An HY, Yeom SD, Lee SJ, Chung HY. NDRG1 and FOXO1 regulate endothelial cell proliferation in infantile haemangioma. Exp Dermatol 2018;27:690-3. [PMID: 29569762 DOI: 10.1111/exd.13541] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
77 Lee JW, Chung HY. Vascular anomalies of the head and neck: current overview. Arch Craniofac Surg 2018;19:243-7. [PMID: 30613084 DOI: 10.7181/acfs.2018.02383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
78 Holland KE, Drolet BA. Infantile Hemangioma. Pediatric Clinics of North America 2010;57:1069-83. [DOI: 10.1016/j.pcl.2010.07.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
79 Moodley ST, Hudson DA, Adams S, Adams KG. Shouldn't Propranolol Be Used to Treat All Haemangiomas? Aesthetic Plast Surg 2015;39:963-7. [PMID: 26377820 DOI: 10.1007/s00266-015-0557-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
80 Lee JC, Modiri O, England RW, Shawber CJ, Wu JK. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta. Plast Reconstr Surg 2021;147:875-85. [PMID: 33776033 DOI: 10.1097/PRS.0000000000007699] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Naughton A, Ong AY, Hildebrand GD. Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers. Pediatr Rep 2021;13:347-56. [PMID: 34287374 DOI: 10.3390/pediatric13030043] [Reference Citation Analysis]
82 Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med. 2010;362:1005-1013. [PMID: 20237346 DOI: 10.1056/nejmoa0903036] [Cited by in Crossref: 148] [Cited by in F6Publishing: 58] [Article Influence: 12.3] [Reference Citation Analysis]
83 Jockin YM, Friedlander SF. Periocular Infantile Hemangioma. International Ophthalmology Clinics 2010;50:15-25. [DOI: 10.1097/iio.0b013e3181e35d35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Oksiuta M, Matuszczak E, Debek W, Dzienis-koronkiewicz E, Hermanowicz A. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature. The Journal of Maternal-Fetal & Neonatal Medicine 2014;29:64-8. [DOI: 10.3109/14767058.2014.986650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
85 Vabres P. [What's new in pediatric dermatology?]. Ann Dermatol Venereol 2008;135 Suppl 7:S343-53. [PMID: 19264210 DOI: 10.1016/S0151-9638(08)75487-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
86 Mizawa M, Matsumura K, Hamazaki K, Furukawa F, Makino T, Shimizu T, Inadera H; Japan Environment and Children’s Study Group. Infantile Hemangioma and the Risk Factors in a Japanese Population: A Nationwide Longitudinal Study-The Japan Environment and Children's Study. J Invest Dermatol 2021:S0022-202X(21)01304-X. [PMID: 34116065 DOI: 10.1016/j.jid.2021.05.011] [Reference Citation Analysis]
87 Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth Defects Res 2017;109:809-15. [PMID: 28402073 DOI: 10.1002/bdr2.1023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
88 Castrén E, Salminen P, Gissler M, Stefanovic V, Pitkäranta A, Klockars T. Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration. Acta Paediatr 2016;105:940-5. [DOI: 10.1111/apa.13460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
89 Caussé S, Aubert H, Saint-jean M, Puzenat E, Bursztejn A, Eschard C, Mahé E, Maruani A, Mazereeuw-hautier J, Dreyfus I, Miquel J, Chiaverini C, Boccara O, Hadj-rabia S, Stalder J, Barbarot S; the Groupe de Recherche Clinique en Dermatologie Pédiatrique. Propranolol-resistant infantile haemangiomas. Br J Dermatol 2013;169:125-9. [DOI: 10.1111/bjd.12417] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
90 Zhang L, Zheng JW, Yuan WE. Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients. Drug Des Devel Ther 2015;9:723-7. [PMID: 25678777 DOI: 10.2147/DDDT.S67682] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
91 Goelz R, Poets CF. Incidence and treatment of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed 2015;100:F85-91. [PMID: 25352093 DOI: 10.1136/archdischild-2014-306197] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
92 Schoch JJ, Hunjan MK, Anderson KR, Lohse CM, Hand JL, Davis DMR, Tollefson MM. Temporal trends in prenatal risk factors for the development of infantile hemangiomas. Pediatr Dermatol 2018;35:787-91. [PMID: 30187967 DOI: 10.1111/pde.13659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
93 Antúnez-Conde R, Navarro Cuéllar C, Salmerón Escobar JI, Díez-Montiel A, Navarro Cuéllar I, Dell'Aversana Orabona G, Del Castillo Pardo de Vera JL, Navarro Vila C, Cebrián Carretero JL. Intraosseous Venous Malformation of the Zygomatic Bone: Comparison between Virtual Surgical Planning and Standard Surgery with Review of the Literature. J Clin Med 2021;10:4565. [PMID: 34640581 DOI: 10.3390/jcm10194565] [Reference Citation Analysis]
94 Reimer A, Fliesser M, Hoeger PH. Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). Journal of the American Academy of Dermatology 2016;75:556-63. [DOI: 10.1016/j.jaad.2016.03.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
95 Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Atti MCD, El Hachem M, Oranje AP, Rubin AT, Weibel L, Léauté-labrèze C. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr 2015;174:855-65. [DOI: 10.1007/s00431-015-2570-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 59] [Article Influence: 12.4] [Reference Citation Analysis]
96 Maclellan RA, Konczyk DJ, Goss JA, Greene AK. Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma. Ann Plast Surg 2018;80:S211-3. [PMID: 29596087 DOI: 10.1097/SAP.0000000000001438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Laranjo S, Costa G, Paramés F, Freitas I, Martins JD, Trigo C, Pinto FF. The role of propranolol in the treatment of infantile hemangioma. Rev Port Cardiol 2014;33:289-95. [PMID: 24906291 DOI: 10.1016/j.repc.2013.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
98 Kowalska M, Dębek W, Matuszczak E. Infantile Hemangiomas: An Update on Pathogenesis and Treatment. J Clin Med 2021;10:4631. [PMID: 34682753 DOI: 10.3390/jcm10204631] [Reference Citation Analysis]
99 Belen B, Oguz A, Okur A, Dalgic B. A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis. BMJ Case Rep 2014;2014:bcr2014203746. [PMID: 24842358 DOI: 10.1136/bcr-2014-203746] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]